Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT04325217
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan
Sponsor: Boehringer Ingelheim
View on ClinicalTrials.gov
Summary
The primary objective is to confirm the incidence of adverse drug reactions (focus on gastrointestinal symptoms including diarrhoea and nausea) to Ofev Capsules seen in clinical trials with real world data generated in patients with SSc-ILD.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
586
Start Date
2020-05-27
Completion Date
2026-06-30
Last Updated
2026-03-17
Healthy Volunteers
No
Conditions
Interventions
DRUG
Nintedanib
Capsules
Locations (1)
Nippon Boehringer Ingelheim Co., Ltd.
Tokyo, Japan